פוטאקטזול 1 מ"ג
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
TOPOTECAN HYDROCHLORIDE 1 MG
Available from:
DEVRIES & CO. LTD
ATC code:
L01XX17
Pharmaceutical form:
POWDER FOR CONCENTRATE FOR SOUTION FOR INFUSION
Administration route:
I.V
Manufactured by:
ACTAVIS GROUP PTC ehf, ICELAND
Therapeutic group:
TOPOTECAN
Therapeutic indications:
Treatment of metastatic carcinoma of the ovary after failure of initial or subsequent therapy. Treatment of small cell lung cancer sensitive disease after failure of first line chemotherapy. Topotecan in combination with cisplatin is indicated for the treatment of Stage IV-B recurrent or persistent carcinoma of the cervix which is not amenable to curative treatment with surgery and/or radiation therapy.
Authorization date:
2012-12-01
